News

Find News

Filter articles

Applied Filters

Showing 61 to 70 of 121 results

Eli Lilly wins mammoth cybersquatting case

International16-08-2016

Eli Lilly has won a cybersquatting case in which the company successfully ordered the transfer of more than 200 domain names that purported to offer discounted erectile dysfunction drugs.

Roche wins cybersquatting case

International11-08-2016

Roche has defeated a cybersquatter in a dispute centring on 18 domain names that infringed trademarks owned by the pharmaceutical company.

New fund to support Australian biomedical discoveries launches

Australia05-08-2016

A new fund dedicated to accelerate the development and commercialisation of Australian biomedical discoveries has officially launched.

Fujifilm signs influenza drug licensing deal

China22-06-2016

Japan-based Fujifilm has signed a patent licensing agreement with a Chinese company centring on an ingredient used in its anti-influenza drug Avigan.

Report predicts generic drugs will soar by 2020

International15-06-2016

The “Global Generic Drugs Market 2016-2020” report predicts that the expiry of patents for branded drugs, worth $150 billion, will allow generic companies to prosper by 2020.

Sequenom targets Ariosa in Australia

Australia08-06-2016

Sequenom has filed a patent infringement lawsuit against Sonic Healthcare, Australian Clinical Labs and Ariosa Diagnostics at the Australian Federal Court.

BIO 2016: Understanding innovation is key to success

International07-06-2016

For something to be innovative it must “add value” and companies must ensure they understand the term in order to succeed, the 2016 BIO International Convention has heard.

‘2016 State of Innovation Report’: Biotech innovation decreases by 2%

International16-05-2016

Biotech was the only technology area out of 12 studied that has shown a global decline in its year-on-year innovation, declining by 2%, according to the “2016 State of Innovation Report: Disruptive, Game-Changing Innovation” by Thomson Reuters.

Gilead gets Sovaldi patent approval in India despite opposition

India10-05-2016

Gilead has been granted a patent for its hepatitis C drug Sovaldi in India, despite concerns over the cost of the drug.

Australia criticised over ‘excessive’ protection for pharma patents

Australia04-05-2016

Australia’s patent system is “poorly targeted” and protection for pharmaceutical inventions is “excessive”, according to a government advisory committee.

Showing 61 to 70 of 121 results

LSIPR